PEMBROBLAD: Real world effectiveness and safety of immune checkpoint inhibitors in patients with advanced urothelial carcinoma with histological variants.

被引：0
|
作者：
Amrane, Karim
Campedel, Luca
Bennamoun, Mostefa
Gabriel, Pierre-Etienne
Brouchet, Nicolas
Pouessel, Damien
Dugage, Matthieu Roulleaux
Thibault, Constance
Cancel, Mathilde
Gout, Mathilde
Flechon, Aude
Huillard, Olivier
Abbar, Baptiste
Borchiellini, Delphine
Doublet, Louis
Augusto-Pelegrin, Laetitia
Elouen, Boughalem
Moinard-Butot, Fabien
Dumont, Clement
Barthelemy, Philippe
机构：
[1] Oncol Dept, Morlaix, France
[2] CHU Clermont Ferrand, Clermont Ferrand, France
[3] Inst Mutualiste Montsouris, Paris, France
[4] Hop St Louis, Paris, France
[5] IUC Oncopole, Toulouse, France
[6] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris Cite, Hop Europeen Georges Pompidou, AP HP Ctr, Inst Canc Paris CARPEM,Dept Pharmacovigilance, Paris, France
[9] Univ Hosp, Dept Med Oncol, Tours, France
[10] Ctr Leon Berard, Lyon, France
[11] Univ Paris Cite, Inst Canc Paris CARPEM, Dept Med Oncol, Hop Cochin,AP HP Ctr, Paris, France
[12] Hop La Pitie Salpetriere, Paris, France
[13] Ctr Antoine Lacassagne, Nice, France
[14] Hop Prive Drome Ardeche, Valence, France
[15] CHU Rouen, Rouen, France
[16] Inst Cancerol Ouest, Angers, France
[17] ICANS Inst Cancerol Strasbourg Europe, Strasbourg, France
[18] APHP Hop St Louis, Paris, France
[19] Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-9718-9794; 261-492-3532-2370-7650-2700; 261-492-2769; 613-135-244-3829; 283-9769-3573-426; 7; 3; 2; 242; 2018; 1; 38092-27449; 38092-31019; 38116-38094-8; 5;
D O I：
10.1200/JCO.2024.42.4_suppl.624
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：624 / 624
页数：1
相关论文
共 50 条
  • [31] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    McLean, Luke S.
    Lim, Annette M.
    Bressel, Mathias
    Thai, Alesha A.
    Rischin, Danny
    DRUGS & AGING, 2024, 41 (03) : 271 - 281
  • [32] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Glenn J. Hanna
    Emily S. Ruiz
    Nicole R. LeBoeuf
    Manisha Thakuria
    Chrysalyne D. Schmults
    James A. Decaprio
    Ann W. Silk
    British Journal of Cancer, 2020, 123 : 1535 - 1542
  • [33] Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients
    Vucinic, Damir
    Skocilic, Iva
    Golcic, Marin
    Dobrila-Dintinjana, Renata
    Kolak, Maja
    Jerkovic, Ivona
    Tesar, Eleonora Cini
    Ferari, Ani Mihaljevic
    Redjovic, Arnela
    Marusic, Jasna
    Kolovrat, Doris
    Mikolasevic, Ivana
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (03):
  • [34] Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
    Gong, Xiaoling
    Zhu, Yahui
    Zhang, Qianning
    Qiu, Xin
    Lu, Changchang
    Tong, Fan
    Wang, Qiaoli
    Kong, Weiwei
    Zhou, Haihui
    Liu, Baorui
    Zhou, Yujie
    Du, Juan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [35] Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma Reply
    Zhao, Joseph J.
    Pietrantonio, Filippo
    Sundar, Raghav
    JAMA ONCOLOGY, 2023, 9 (07) : 1005 - 1006
  • [36] Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes
    Esagian, Stepan M.
    Khaki, Ali Raza
    Diamantopoulos, Leonidas N.
    Carril-Ajuria, Lucia
    Castellano, Daniel
    De Kouchkovsky, Ivan
    Park, Joseph J.
    Alva, Ajjai
    Bilen, Mehmet A.
    Stewart, Tyler F.
    McKay, Rana R.
    Santos, Victor S.
    Agarwal, Neeraj
    Jain, Jayanshu
    Zakharia, Yousef
    Morales-Barrera, Rafael
    Devitt, Michael E.
    Nelson, Ariel
    Hoimes, Christopher J.
    Shreck, Evan
    Gartrell, Benjamin A.
    Sankin, Alex
    Tripathi, Abhishek
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Rodriguez-Vida, Alejo
    Drakaki, Alexandra
    Liu, Sandy
    Kumar, Vivek
    Lythgoe, Mark P.
    Pinato, David J.
    Murgic, Jure
    Frobe, Ana
    Joshi, Monika
    Isaacsson Velho, Pedro
    Hahn, Noah
    Alonso Buznego, Lucia
    Duran, Ignacio
    Moses, Marcus
    Barata, Pedro
    Galsky, Matthew D.
    Sonpavde, Guru
    Yu, Evan Y.
    Msaouel, Pavlos
    Koshkin, Vadim S.
    Grivas, Petros
    BJU INTERNATIONAL, 2021, 128 (02) : 196 - 205
  • [37] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Tsai, Hong-Ming
    Han, Meng-Zhi
    Lin, Yih-Jyh
    Chang, Ting-Tsung
    Chen, Chiung-Yu
    Cheng, Pin-Nan
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Chen, Po-Jun
    Kang, Jui-Wen
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Kuo, Hsin-Yu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1929 - 1937
  • [38] Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Dawsey, Scott
    Gupta, Shilpa
    Carril-Ajuria, Lucia
    Castellano, Daniel
    de Kouchkovsky, Ivan
    Koshkin, Vadim S.
    Park, Joseph J.
    Alva, Ajjai
    Bilen, Mehmet A.
    Stewart, Tyler F.
    Mckay, Rana R.
    Tripathi, Nishita
    Agarwal, Neeraj
    Vather-Wu, Naomi
    Zakharia, Yousef
    Morales-Barrera, Rafael
    Devitt, Michael E.
    Cortellini, Alessio
    Fulgenzi, Claudia Angela Maria
    Pinato, David J.
    Nelson, Ariel
    Hoimes, Christopher J.
    Gupta, Kavita
    Gartrell, Benjamin A.
    Sankin, Alex
    Tripathi, Abhishek
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Murgic, Jure
    Frobe, Ana
    Rodriguez-Vida, Alejo
    Drakaki, Alexandra
    Liu, Sandy
    Lu, Eric
    Kumar, Vivek
    Di Lorenzo, Giuseppe
    Joshi, Monika
    Isaacsson-Velho, Pedro
    Buznego, Lucia Alonso
    Duran, Ignacio
    Moses, Marcus
    Jang, Albert
    Barata, Pedro
    Sonpavde, Guru
    Yu, Evan Y.
    Montgomery, Robert Bruce
    CLINICAL GENITOURINARY CANCER, 2022, 20 (05) : E440 - E452
  • [39] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Hong-Ming Tsai
    Meng-Zhi Han
    Yih-Jyh Lin
    Ting-Tsung Chang
    Chiung-Yu Chen
    Pin-Nan Cheng
    Chiao-Hsiung Chuang
    I-Chin Wu
    Po-Jun Chen
    Jui-Wen Kang
    Yen-Cheng Chiu
    Hung-Chih Chiu
    Shih-Chieh Chien
    Hsin-Yu Kuo
    Cancer Immunology, Immunotherapy, 2021, 70 : 1929 - 1937
  • [40] Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis
    Mencoboni, Manlio
    Ceppi, Marcello
    Bruzzone, Marco
    Taveggia, Paola
    Cavo, Alessia
    Scordamaglia, Francesca
    Gualco, Marina
    Filiberti, Rosa Angela
    CANCERS, 2021, 13 (06) : 1 - 22
12345